| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Senior VP, R&D
1 company
Kuriyel Ralf is a Senior VP, R&D at REPLIGEN CORP. Recent SEC Form 4 filings include 0 buys and 18 sells.
Estimated insider holdings value: $2.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 2, 2024 | RGEN Repligen Corp | Senior VP, R&D | Sale+OE | 7,148 | $159.35 | $1,139,016.03 | -22.5% | -16.9% | -26.4% | |
| Aug 1, 2024 | RGEN Repligen Corp | Senior VP, R&D | Sell | 4,465 | $165.67 | $739,716.55 | -18.8% | -17.7% | -28.2% | |
| Mar 11, 2024 | RGEN Repligen Corp | Senior VP, R&D | Sale+OE | 3,517 | $193.73 | $681,348.41 | -12.7% | -26.9% | -23.8% | |
| Aug 11, 2022 | RGEN Repligen Corp | Senior VP, R&D | Sale+OE | 4,840 | $254.32 | $1,230,885.60 | -10.2% | -29.1% | -30.1% | |
| Aug 30, 2021 | RGEN Repligen Corp | Senior VP, R&D | Sell | 4,001 | $282.13 | $1,128,802.13 | -18.7% | +2.9% | -22.3% | |
| Jun 10, 2021 | RGEN Repligen Corp | Senior VP, R&D | Sale+OE | 6,802 | $189.19 | $1,286,870.38 | -24.2% | +54.9% | -21.5% | |
| May 14, 2021 | RGEN Repligen Corp | Senior VP, R&D | Sell | 710 | $172.29 | $122,325.90 | -2.8% | +48.4% | -12.5% | |
| Mar 10, 2021 | RGEN Repligen Corp | Senior VP, R&D | Sale+OE | 8,000 | $190.44 | $1,523,500.70 | -9.3% | -10.5% | -15.7% | |
| Mar 4, 2021 | RGEN Repligen Corp | Senior VP, R&D | Sell | 2,075 | $192.00 | $398,395.50 | -1.6% | - | - | |
| Dec 16, 2020 | RGEN Repligen Corp | Senior VP, R&D | Sell | 435 | $186.18 | $80,988.30 | -1.7% | - | - |